The decision will push back the scheduled conclusion of Denmark's vaccination scheme to early August from July 25, health authorities said. Results of investigations into the AstraZeneca-associated blood clots "showed real and serious side-effects," Danish health agency head Soren Brostrom told a news briefing. The European Union's drug watchdog said last week it had found a possible link between the AstraZeneca vaccine and cerebral venous sinus thrombosis (CVST), a brain blood clot. Denmark was the first country to initially suspend all use of the AstraZeneca vaccine in March over safety concerns. Denmark is in the process of easing restrictions after its daily COVID-19 infection rate slowed to 500-600 from several thousand in December.

Source: bd News24 April 14, 2021 14:48 UTC